Commodore Capital’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Other funds holding TNGX
SL
Commodore Capital's TNGX Position: Q3 2026 in Review
Commodore Capital sold out of Tango Therapeutics (TNGX) in Q3 2026, closing a stake of 2,250,000 shares — an estimated $70.3M sold.
Commodore Capital first reported a position in TNGX in Q2 2025 and held it in 3 quarters. The position peaked at $70.3M in Q2 2026. 246 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.
- Commodore Capital reported no remaining Tango Therapeutics position as of Q3 2026 after selling out during the quarter.
- Commodore Capital sold 2,250,000 Tango Therapeutics shares in Q3 2026, an estimated $70.3M.
- Commodore Capital first reported a position in Tango Therapeutics in Q2 2025 and held it in 3 quarters.
- Commodore Capital's Tango Therapeutics position peaked at $70.3M in Q2 2026.
- 246 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.
Based on Commodore Capital's 13F filing for Q3 2026, filed 16 Nov 2026.